BioHarvest Sciences Inc.
BHST
Get informed when a big investor buys or sells
+ FollowMarket Cap$28.76M
Close$
Share Statistics
| Market cap | $28.76 Million |
|---|---|
| Enterprise Value | $30.50 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.6 |
| Beta | 1.38 |
| Outstanding Shares | 22,667,842 |
Return
| Return on Equity | -56.03% |
|---|---|
| Return on Assets | -24.84% |
| Return on Invested Capital | -27.45% |
Valuation & Multiples
| P/E Ratio | -3.07 |
|---|---|
| PEG | 34.36 |
| Price to Sales | 1.75 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.86 |
| Enterprise Value to EBIT | -3.38 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.59 |
| Debt to Equity | 0.91 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.13
Average shareholder expectationRevenue Estimate
$9.45 M
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.16
Average shareholder expectationRevenue Estimate
$9.31 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About BioHarvest Sciences Inc.
89 employees
CEO: Zaki Rakib BioHarvest Sciences Inc. is a biotechnology company that operates through two segments: Products and CDMO Services. The company has developed a botanical synthesis platform technology to grow plant cells with higher concentrations of act...